These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 27472963)
1. Oxidized LDL at the crossroads of immunity in non-alcoholic steatohepatitis. Houben T; Brandsma E; Walenbergh SMA; Hofker MH; Shiri-Sverdlov R Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Apr; 1862(4):416-429. PubMed ID: 27472963 [TBL] [Abstract][Full Text] [Related]
2. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients. Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071 [TBL] [Abstract][Full Text] [Related]
3. MSP is a negative regulator of inflammation and lipogenesis in ex vivo models of non-alcoholic steatohepatitis. Chanda D; Li J; Oligschlaeger Y; Jeurissen ML; Houben T; Walenbergh SM; Shiri-Sverdlov R; Neumann D Exp Mol Med; 2016 Sep; 48(9):e258. PubMed ID: 27609031 [TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. Walenbergh SM; Koek GH; Bieghs V; Shiri-Sverdlov R J Hepatol; 2013 Apr; 58(4):801-10. PubMed ID: 23183522 [TBL] [Abstract][Full Text] [Related]
6. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240 [TBL] [Abstract][Full Text] [Related]
7. Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis. Musso G; Gambino R; De Michieli F; Biroli G; Fagà E; Pagano G; Cassader M Ann Med; 2008; 40(5):383-94. PubMed ID: 18484349 [TBL] [Abstract][Full Text] [Related]
8. Innate immune regulatory networks in hepatic lipid metabolism. Bai L; Li H J Mol Med (Berl); 2019 May; 97(5):593-604. PubMed ID: 30891617 [TBL] [Abstract][Full Text] [Related]
9. The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH). Nati M; Haddad D; Birkenfeld AL; Koch CA; Chavakis T; Chatzigeorgiou A Rev Endocr Metab Disord; 2016 Mar; 17(1):29-39. PubMed ID: 26847547 [TBL] [Abstract][Full Text] [Related]
11. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters. Lai YS; Yang TC; Chang PY; Chang SF; Ho SL; Chen HL; Lu SC J Nutr Biochem; 2016 Apr; 30():44-52. PubMed ID: 27012620 [TBL] [Abstract][Full Text] [Related]
12. LDL-migration index (LDL-MI), an indicator of small dense low-density lipoprotein (sdLDL), is higher in non-alcoholic steatohepatitis than in non-alcoholic fatty liver: a multicenter cross-sectional study. Imajo K; Hyogo H; Yoneda M; Honda Y; Kessoku T; Tomeno W; Ogawa Y; Taguri M; Mawatari H; Nozaki Y; Fujita K; Kirikoshi H; Saito S; Sumida Y; Ono M; Wada K; Nakajima A; Eguchi Y PLoS One; 2014; 9(12):e115403. PubMed ID: 25541989 [TBL] [Abstract][Full Text] [Related]
13. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211 [TBL] [Abstract][Full Text] [Related]